Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis

Endocrine Journal

Volumn 61, Issue 7, 2014, Pages 735-742

  Ariyasu, Hiroyuki ^a,b,e   Iwakura, Hiroshi ^a,b   Yukawa, Naoichiro ^c   Murayama, Toshinori ^a   Yokode, Masayuki ^a   Tada, Harue ^a   Yoshimura, Kenichi ^a   Teramukai, Satoshi ^a   Ito, Tatsuya ^a   Shimizu, Akira ^a   Yonezawa, Atsushi ^a   Kangawa, Kenji ^d   Mimori, Tsuneyo ^c   Akamizu, Takashi ^a,e  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric motility; Ghrelin; Systemic sclerosis

Indexed keywords

GASTROINTESTINAL AGENT; GHRELIN; GHRL PROTEIN, HUMAN; NEW DRUG;

AGED; BEVERAGE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; GASTROINTESTINAL TRACT; GASTROPARESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; STOMACH EMPTYING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BEVERAGES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUGS, INVESTIGATIONAL; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRACT; GASTROPARESIS; GHRELIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SATIETY RESPONSE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84905171656     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0088     Document Type: Note

References (40)

1. Sjogren RW (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37: 1265-1282.
2. Forbes A, Marie I (2009) Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) 48 Suppl 3: iii36-39.
3. D'Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fiftyeight matched controls. Am J Med 46: 428-440.
4. Bortolotti M, Turba E, Tosti A, Sarti P, Brunelli F, et al. (1991) Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 86: 743-747.
5. Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32: 348-355.
6. Maddern GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, et al. (1984) Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 87: 922-926.
7. Marycz T, Muehldorfer SM, Katalinic A, Herold C, Ell C, et al. (1999) Gastric involvement in progressive systemic sclerosis: electrogastrographic and sonographic findings. Eur J Gastroenterol Hepatol 11: 1151-1156.
8. Mittal BR, Wanchu A, Das BK, Ghosh PP, Sewatkar AB, et al. (1996) Pattern of gastric emptying in patients with systemic sclerosis. Clin Nucl Med 21: 379-382.
9. Sridhar KR, Lange RC, Magyar L, Soykan I, McCallum RW. (1998) Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications. J Lab Clin Med 132: 541-546.
10. Wedmann B, Wegener M, Adamek RJ, el Gammal S (1994) Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis: a sonographic study. Dig Dis Sci 39: 565-570.
11. Wegener M, Adamek RJ, Wedmann B, Wedmann B, Jergas M, et al. (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39: 2209-2215.
12. Marie I, Gourcerol G, Leroi AM, Ménard JF, Levesque H, et al. (2012) Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis. Arthritis Rheum 64: 2346-2355.
13. Johnson DA, Drane WE, Curran J, Benjamin SB, Chobanian SJ, et al. (1987) Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities. Arch Intern Med 147: 1597-1601.
14. Smout AJ, Bogaard JW, Grade AC, ten Thije OJ, Akkermans LM, et al. (1985) Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal oesophagus in man. Gut 26: 246-251.
15. Soudah HC, Hasler WL, Owyang C. (1991) Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 325: 1461-1467.
16. Dull JS, Raufman JP, Zakai MD, Strashun A, Straus EW (1990) Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis. Am J Med 89: 528-530.
17. Tomomasa T, Kuroume T, Arai H, Wakabayashi K, Itoh Z (1986) Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 31: 157-161.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
19. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, et al. (2001) Stomach is a major source of circulating ghre lin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86: 4753-4758.
20. Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, et al. (2006) Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab 91: 3296-3302.
21. Murray CD, Martin NM, Patterson M, Taylor SA, Ghatei MA, et al. (2005) Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54: 1693-1698.
22. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, et al. (2005) Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 22: 847-853.
23. Binn M, Albert C, Gougeon A, Maerki H, Coulie B, et al. (2006) Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 27: 1603-1606.
24. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, et al. (2013) Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care 36: 41-48.
25. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, et al. (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992- 5995.
26. Braden B, Adamas S, Duan L, Orth KH, Maul FD, et al. (1995) The 13C acetate breath test accurately reflects gastric emptying of liquids in both liquids and semisolid test meals. Gastroenterology 108: 1048-1055.
27. Akamizu T, Iwakura H, Ariyasu H, Hosoda H, Murayama T, et al. (2008) Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 158: 491- 498.
28. Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, et al. (2004) Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 150: 447-455.
29. Thompson DA, Campbell RG (1977) Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science 198: 1065- 1068.
30. Ariyasu H, Iwakura H, Yamada G, Kanamoto N, Bando M, et al. (2010) A postweaning reduction in circulating ghrelin temporarily alters growth hormone (GH) responsiveness to GH-releasing hormone in male mice but does not affect somatic growth. Endocrinology 151: 1743-5170.
31. Akamizu T, Iwakura H, Ariyasu H, Murayama T, Sumi E, et al. (2008) Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc 56: 2363-2365.
32. Cohen S, Fisher R, Lipshutz W, Turner R, Myers A, et al. (1972) The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 51: 2663-2668.
33. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, et al. (2003) Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 550: 227-240.
34. Edholm T, Levin F, Hellström PM, Schmidt PT (2004) Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 121: 25-30.
35. Xu L, Depoortere I, Tomasetto C, Zandecki M, Tang M, et al. (2005) Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept 124: 119-125.
36. Dass NB, Munonyara M, Bassil AK, Hervieu GJ, Osbourne S, et al. (2003) Growth hormone secret agogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120: 443-453.
37. Fukuda H, Mizuta Y, Isomoto H, Takeshima F, Ohnita K, et al. (2004) Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 39: 1209-1214.
38. Bassil AK, Dass NB, Sanger GJ (2006) The prokineticlike activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurons. Eur J Pharmacol 544: 146-152.
39. Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL (2005) Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 54: 1078-1084.
40. Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, et al. (2005) Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol 515: 160-168.